AFTER 5th_IOBDLI FORUM
​> ATTENDEES
> PRESENTERS
> INVESTORS
​> SPONSOR & SUPPORTERS

Confirmed attending companies include:

4C Biomed Services Ltd.
7 Hills Pharma LLC
Aarhus University
AbbVie Ventures
AbbVie, Inc.
Adaptimmune
Affinity Asset Advisors, LLC
AgonOx, Inc.
Aleta Biotherapeutics
Alkermes Plc.
Ally Bridge Group
Alpha Bronze
ALSA Holdings
Alta Partners Management Corp.
Amgen, Inc.
Andreessen Horowitz
Anixa Biosciences, Inc.
Arch Venture Partners
Astellas Innovation Management LLC
Astellas Pharma, Inc.
AstraZeneca
Bailard, Inc.
BeiGene Ltd.
BioInvent International AB
Biotech Alliances International, Inc.
BOHE Angel Fund
Brookline Capital Markets
BVF Partners, L.P.
Cancer Research Institute
Cancer Research UK
Capital One Healthcare
Caribou Biosciences, Inc.
CBC Group (C-Bridge Capital)
Cello Health BioConsulting, previously Defined Health
Celyad
Cleveland Clinic
Compass Therapeutics LLC
Convergent R.N.R Ltd.
Cowen, Inc.
Credit Suisse Group AG
Daiichi Sankyo, Inc.
Deca Ventures
Deerfield Management
Dresner Corporate Services (DCS) (part of Dresner Partners)
DS Asset Management Co., Ltd.
Eli Lilly and Company
Emerging Technology Partners, LLC (ETP)
EpiVax Oncology, Inc.
ESC Advisors
EXUMA Biotechnology SEZC
F. Hoffmann-La Roche Ltd.
F1 Oncology
F1BioVentures LLC
Faron Pharmaceuticals Ltd.
Fortress Biotech
Fraser Finance LLP
Fred Hutchinson Cancer Research Center
FreeMind Group
Genentech, Inc.
Genocea Biosciences, Inc.
Genprex, Inc.
GlaxoSmithKline
Good Health Capital LLC
Gurnet Point Capital
H.C. Wainwright & Co., LLC
Halozyme Therapeutics, Inc.
HitchinRock Advisors
Hutchison China MediTech Ltd.
ICR, Inc.
Illumina Ventures
Image Analysis Group
Immunicom, Inc.
Immunicum AB
Immunomic Therapeutics, Inc.
Immunophotonics, Inc.

Indaco Venture Partners SGR
Innovation Norway
JAFCO Co., Ltd.
Jefferies Group LLC
Jemincare Therapeutics Corp.
Johnson & Johnson Innovation
Kleo Pharmaceuticals, Inc.
L.E.K. Consulting
Ladenburg, Thalmann & Co., Inc.
Lazard Ltd.
Lilly Asia Ventures
Lincoln Park Capital Fund, LLC
Loncar Investment LLC
Marker Therapeutics, Inc. (formerly TapImmune Inc.)
Medikine, Inc.
Mediqventures
Medivate Partners
Merck KGaA
Milestone Capital
Moffitt Cancer Center Foundation
MPM Capital, Inc.
MSF Capital Advisors LLC
MSQ Ventures
MTS Health Partners
New Enterprise Associates (NEA)
Nextech Invest Ltd.
NOXXON Pharma NV
Oasmia Pharmaceutical AB
Oncology Venture A/S
Oncomatryx Biopharma, S.L.
OpenWater Capital
Oppenheimer & Co. Inc.
OrbiMed Advisors LLC
Orthogon Therapeutics, LLC
OSE Immunotherapeutics
Oxford BioMedica Plc.
Paulson Investment Company, LLC
PBM Capital
Pelican Therapeutics
Pfizer, Inc.
Phio Pharmaceuticals Corp.
Prevail Partners LLC
PsiOxus Therapeutics Ltd.
Pullan Consulting
Rainier Therapeutics, Inc.
RBV Capital
Real Endpoints LLC
Refuge Biotechnologies, Inc. 
Sachs Associates Ltd.
Sand Hill Angels
Sangel Capital
SciNote LLC
Shanghai Fosun Pharmaceutical Co., Ltd.
Sirnaomics, Inc.
SIWA Therapeutics, Inc.
Starlink Capital, Inc.
Stifel Financial Corp.
Suenos Advisors Est.
Taiho Ventures, LLC
Takeda Pharmaceutical Company
The Life Sciences Division Ltd.
The Mark Foundation for Cancer Research
TikoMed AB
Tracon Pharmaceuticals
Triumvira Immunologics, Inc.
UNUM Capital
VCN Biosciences SL
Vertex Ventures HC
Virtus Inspire Ventures
Vybyl Biopharma
WBB Securities LLC
William Blair & Co., LLC
X-Chem, Inc.
Yafo Capital
Zumutor Biologics, Inc.

*Updated on 22.05